XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Share-Based Compensation

NOTE 6 – Share-Based Compensation

The table below sets forth information related to our share-based compensation expense:

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Cost of goods sold

$

485

 

 

$

390

 

 

$

1,168

 

 

$

946

 

Selling, general and administrative

 

8,529

 

 

 

8,690

 

 

 

22,309

 

 

 

21,350

 

Research and development

 

1,197

 

 

 

1,081

 

 

 

3,247

 

 

 

2,629

 

Total share-based compensation expense

$

10,211

 

 

$

10,161

 

 

$

26,724

 

 

$

24,925

 

Share Grants – Share grants consist of restricted stock awards, restricted stock units and performance stock units ("PSUs"). Restricted stock awards and restricted stock units generally vest in equal annual installments over a four-year period and are measured based on the fair market value of the underlying stock on the date of grant. Compensation expense is recognized on a straight-line basis over the requisite four-year service period. All new grants are granted under the Company’s 2022 Equity Incentive Plan.

Performance stock units (“PSUs”) are measured based on the fair market value of the underlying stock on the date of grant, and compensation expense is recognized over the three-year performance period, with adjustments made to the expense to recognize the probable payout percentage.

As of September 30, 2022, total unrecognized share-based compensation expense related to share grants was approximately $72.6 million, before income taxes, and is expected to be recognized over a weighted average period of approximately 2.3 years.

Stock Options –We recognized stock option expense of less than $30 thousand for each of the three month periods ended September 30, 2022 and 2021. We recognized stock option expense of less than $55 thousand for each of the nine month periods ended September 30, 2022 and 2021. All stock option expense is related to stock options granted by Savitech Corporation (“Savitech”) in Savitech stock to their employees. We acquired a controlling interest in Savitech in 2020.